EDGAR Filing Documents for 0001016169-12-000005

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001016169-12-000005

Filing Date

2012-03-12

Accepted

2012-03-12 17:27:19

Documents

Period of Report

2011-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		k10.htm	10-K	1608922
2		kaushik.htm	EX-10.18	173251
3		corplease.htm	EX-10.21	835962
4		corplease0.jpg	GRAPHIC	226110
5		ex211.htm	EX-21.1	6401
6		ex231.htm	EX-23.1	5163
7		ex311.htm	EX-31.1	14006
8		ex312.htm	EX-31.2	14016
9		ex321.htm	EX-32.1	6640
10		ex322.htm	EX-32.2	6651
11		k100.jpg	GRAPHIC	49853
12		arrow.jpg	GRAPHIC	99492
13		pressrelease.htm	EX-99.1	134769
14		logo1.jpg	GRAPHIC	8792
	Complete submission text file	0001016169-12-000005.txt		5780087

Data Files

Seq	Document	Type	Size
15	ais-20111231.xml	EX-101.INS	498782
16	ais-20111231.xsd	EX-101.SCH	15784
17	ais-20111231_cal.xml	EX-101.CAL	44740
18	ais-20111231_def.xml	EX-101.DEF	19059
19	ais-20111231_lab.xml	EX-101.LAB	195728
20	ais-20111231_pre.xml	EX-101.PRE	104998

Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618

Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020

ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)